I understand it’s judgment day your referring to when you say “our day in court” what will our results be.
On a more positive outlook for me. Not that anyone would expect me to be positive. I will use... “our day in the sun”. Only because when Virologix was first used in Covid on patients. The patients were the worst possible terminal patients you would expect. All having some kind of organ transplant and most of them were lung transplants I believe.
As anecdotal evidence only we know that those terminal patients survived at a rate of 6 of 10 patients. If we have severe or critical patients that are approaching organ failure of some kind in our current CD-12 trial. That are on life support you might have some similar expectations of those patients. But I believe our average patient all though severe/criticize will be in a little better condition.
This bodes well in my opinion for unblinding with the average severe/critical positive Covid not having a recent organ transplant patient will have a better overall chance at survival with Vyrologix. So in theory... not only a better chance at survival but better percentage of survival one would think for our trial results.
Either way you look at it... as a “day in the sun” because we will now know our results or as “day in court” we will know what we have.
Unblinding a drug that is in so much need right now. When you have Americans dying at a rate of more than one every minute of the day from COVID-19. We have to hope that we make a big difference. I believe we will. I believe what Dr. Patterson said of Leronlimab... as if it was almost designed for COVID-19. Let the truth be known. It’s our time to shine.
On a more positive outlook for me. Not that anyone would expect me to be positive. I will use... “our day in the sun”. Only because when Virologix was first used in Covid on patients. The patients were the worst possible terminal patients you would expect. All having some kind of organ transplant and most of them were lung transplants I believe.
As anecdotal evidence only we know that those terminal patients survived at a rate of 6 of 10 patients. If we have severe or critical patients that are approaching organ failure of some kind in our current CD-12 trial. That are on life support you might have some similar expectations of those patients. But I believe our average patient all though severe/criticize will be in a little better condition.
This bodes well in my opinion for unblinding with the average severe/critical positive Covid not having a recent organ transplant patient will have a better overall chance at survival with Vyrologix. So in theory... not only a better chance at survival but better percentage of survival one would think for our trial results.
Either way you look at it... as a “day in the sun” because we will now know our results or as “day in court” we will know what we have.
Unblinding a drug that is in so much need right now. When you have Americans dying at a rate of more than one every minute of the day from COVID-19. We have to hope that we make a big difference. I believe we will. I believe what Dr. Patterson said of Leronlimab... as if it was almost designed for COVID-19. Let the truth be known. It’s our time to shine.
4
